Oh boy. You sure about that? There are two big medical regulatory bodies. the FDA and the EMA. Countries that are not part of the EMA tend to look to the FDA for a drug's approval before they will use it. If it was so easy to get new drugs used in other countries, companies would just go there and bypass the FDA. They don't because the FDA's approval is the GOLD STANDARD and tells the rest of the world the drug is safe (the FDA gets this wrong as well which should tell you all you need to know about the FDA). Then there is the EMA that covers many european countries. EMA approval doesn't guarantee FDA approval and vice versa.
And if these were trials, they would be material info which the company would have to disclose. So far, nothing has been said by Koos about any trials being performed at all. So again, my guess is that some are incorrectly attaching meaning to two things where there is no relationship.
News 
Market Data 
Discover 
AI
